Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis ILD - Article

Review guidance for the identification and medical management of systemic sclerosis-associated ILD in this concise clinical review from the American Thoracic Society.

What you’ll learn:

• The pathogenesis of SSc-ILD
• The genetics and epigenetics associated with the disease
• The cellular pathogenesis of fibrotic lung injury in SSc
• Risk factors for the development and progression of SSc-ILD
• Blood serum and BAL fluid markers used in SSc-ILD diagnosis and prognostication
• Characteristics of IPF compared to SSc-ILD, and the importance of differentiation between the two diseases